Headache and the risk of stroke

被引：7

作者：

Jousilahti P. ^{[1
]}

机构：

[1] Department of Public Health, University of Helsinki, FIN-00014 Helsinki

来源：

Current Atherosclerosis Reports | 2004年 / 6卷 / 4期

关键词：

Migraine; Ischemic Stroke; Migraine Patient; Migraine With Aura; Ergotamine;

D O I：

10.1007/s11883-004-0065-y

中图分类号：

学科分类号：

摘要：

Several studies have suggested that migraine is a risk factor for stroke. The association between migraine and the risk of stroke has been observed most often among premenopausal women but also in some studies among men. The association may be stronger among women who smoke and among women using oral contraceptives compared with nonsmokers and nonusers. Classic migraine with aura may be a more powerful predictor of stroke than common migraine without aura. Findings of a recent population-based study suggest that subclinical brain lesions are more common among migraine patients, particularly among those with aura, than among the control subjects. Two cohort studies have shown that chronic non-specific headache also is related to increased stroke risk. The effect of treatment of migraine and other types of headache on the risk of stroke is not known. Even though the relative risk of stroke may be fairly high among migraine patients, the absolute risk is usually low due to low baseline risk among young people. Copyright © 2004 by Current Science Inc.

引用

页码：320 / 325

页数：5

共 33 条

[1]

Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain, Cephalalgia, 8, SUPPL. 7, pp. 1-96, (1988)

[2]

Stewart W.F., Shechter A., Rasmussen B.K., Migraine prevalence. A review of population-based studies, Neurology, 44, 6 SUPPL. 4, (1994)

[3]

Ferrari M.D., Migraine, Lancet, 351, pp. 1043-1051, (1998)

[4]

Rasmussen B.K., Jensen R., Schroll M., Olesen J., Epidemiology of headache in a general population - A prevalence study, J. Clin. Epidemiol., 44, pp. 1147-1157, (1991)

[5]

Sudlow C.L., Warlow C.P., Comparable studies of the incidence of stroke and its pathological types: Results from an international collaboration, Stroke, 28, pp. 491-499, (1997)

[6]

Marmot M.G., Poulter N.R., Primary prevention of stroke, Lancet, 339, pp. 344-347, (1992)

[7]

Hankey G.J., Role of lipid-modifying therapy in the prevention of initial and recurrent stroke, Curr. Opin. Lipidol., 13, pp. 645-651, (2002)

[8]

Bots M.L., Elwood P.C., Nikitin Y., Et al., Total and HDL cholesterol and risk of stroke. EUROSTROKE: A collaborative study among research centres in Europe, J. Epidemiol. Community Health, 56, SUPPL. 1, (2002)

[9]

Schwartz S.M., Petitti D.B., Siscovick D.S., Et al., Stroke and use of low-dose oral contraceptives in young women: A pooled analysis of two US studies, Stroke, 29, pp. 2277-2284, (1998)

[10]

Oral contraceptives and stroke in young women: Associated risk factors, JAMA, 231, pp. 718-722, (1975)

← 1 2 3 4 →